Response to 'The use of tenofovir in patients with COVID-19'

HIV Med. 2022 Sep;23(8):929-930. doi: 10.1111/hiv.13278. Epub 2022 Feb 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19 Drug Treatment*
  • HIV Infections* / drug therapy
  • Humans
  • Lamivudine / therapeutic use
  • Tenofovir / therapeutic use

Substances

  • Antiviral Agents
  • Lamivudine
  • Tenofovir